Tandem Diabetes Care (TNDM) Capital Expenditures Growth (1y) (2014 - 2026)
Powered by 
Analysis
Tandem Diabetes Care (TNDM) Capital Expenditures Growth (1y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.78 Bn | 175.17 Bn | 7.27 Bn | -1.00% |
| 2 | Intuitive Surgical | 127.04 Bn | 121.82 Bn | 1.96 Bn | -27.50% |
| 3 | Medtronic | 117.04 Bn | 108.22 Bn | 6.34 Bn | -0.20% |
| 4 | Stryker | 103.86 Bn | 100.38 Bn | 4.50 Bn | 10.38% |
| 5 | Boston Scientific | 63.50 Bn | 62.96 Bn | 3.85 Bn | 24.20% |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn | 35.70% |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn | 5.88% |
| 8 | Dexcom | 32.12 Bn | 30.17 Bn | 830.00 Mn | -9.99% |
| 9 | Steris | 20.69 Bn | 20.21 Bn | 684.20 Mn | -6.52% |
| 10 | Tandem Diabetes Care | 1.27 Bn | 811.05 Mn | 144.78 Mn | -47.49% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -47.49% |
| Mar 31, 2026 | 103.12% |
| Dec 31, 2025 | 117.82% |
| Sep 30, 2025 | -21.89% |
| Jun 30, 2025 | -23.04% |
| Mar 31, 2025 | -5.88% |
| Dec 31, 2024 | -40.97% |
| Sep 30, 2024 | -2.98% |
| Jun 30, 2024 | -12.35% |
| Mar 31, 2024 | -49.51% |
| Dec 31, 2023 | -7.61% |
| Sep 30, 2023 | -60.61% |
| Jun 30, 2023 | -39.12% |
| Mar 31, 2023 | 234.01% |
| Dec 31, 2022 | -2.07% |
| Sep 30, 2022 | 342.97% |
| Jun 30, 2022 | 567.60% |
| Mar 31, 2022 | -25.00% |
| Dec 31, 2021 | 40.28% |
| Sep 30, 2021 | -54.22% |